tradingkey.logo
tradingkey.logo
Search

TScan Therapeutics Inc

TCRX
Add to Watchlist
0.161USD
-0.007-4.17%
Close 11-13 16:00(ET)
10.91MMarket Cap
LossP/E TTM

Today

-4.17%

5 Days

-14.36%

1 Month

-32.64%

6 Months

-83.90%

Year to Date

-83.90%

1 Year

-85.36%

Key Figures

0.174Open
0.183High
35.22KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.05%Turnover Ratio
0.168Prev. Close
0.160Low
5.76KTurnover
LossP/E Static
0.29P/B
0.00%Div Yield TTM
-46.50%ROA
1.47052wk High
0.07Volume Ratio
-127.50MNet Profit
67.78MShares
-0.9574EPS TTM
1.04Beta
-80.95%ROE
0.16052wk Low
13.69%Amplitude
100.00%Gross Margin
10.91MMarket Cap
-3.20Reward/Risk
5.91%Risk Rate
More news coming soon, stay tuned...

TScan Therapeutics Inc's Score

0.00vs previous score
Forecast6.80
Financial Health5.67
Technical4.98
Valuation Dimensions9.04
Institutional Confidence5.00
Risk Assessment1.81

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
HoldCurrent Rating
2.667Target Price
+1428.18%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy00111111
Buy22444444
Hold35222222
Sell00000000
Strong Sell00000000

TScan Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.25/-0.19
Revenue / Forecast
586.00K/459.00K

TScan Therapeutics Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolTCRX
Number of employees194
CountryUnited States of America

Ownership

ShareholdersProportion
Lynx1 Capital Advisors LLC13.13%
BVF Partners L.P.8.56%
K2 HealthVentures LLC5.90%
Baker Bros. Advisors LP4.56%
Shareholder TypesProportion
Investment Advisor20.75%
Hedge Fund18.58%
Venture Capital8.30%
Investment Advisor/Hedge Fund6.39%

FAQs

What is the current price of TScan Therapeutics Inc (TCRX)?

The current price of TScan Therapeutics Inc (TCRX) is 0.16.

What is the symbol of TScan Therapeutics Inc?

The ticker symbol of TScan Therapeutics Inc is TCRX.

What is the 52-week high of TScan Therapeutics Inc?

The 52-week high of TScan Therapeutics Inc is 1.47.

What is the 52-week low of TScan Therapeutics Inc?

The 52-week low of TScan Therapeutics Inc is 0.16.

What is the market capitalization of TScan Therapeutics Inc?

The market capitalization of TScan Therapeutics Inc is 10.91M.

Is TScan Therapeutics Inc (TCRX) currently rated as Buy, Hold, or Sell?

According to analysts, TScan Therapeutics Inc (TCRX) has an overall rating of signal_hold, with a price target of 2.67.

What is the Earnings Per Share (EPS TTM) of TScan Therapeutics Inc (TCRX)?

The Earnings Per Share (EPS TTM) of TScan Therapeutics Inc (TCRX) is -0.96.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.